| 摘要 |
<p>The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema.</p> |
| 申请人 |
GLAXO GROUP LIMITED;WAN, ZEHONG;ZHANG, XIAOMIN;TONG, ZHAOLONG;LONG, KAI;DOWDELL, SARAH E.;MANAS, ERIC STEVEN;GOODMAN, KRISTA BEAVER |
发明人 |
WAN, ZEHONG;ZHANG, XIAOMIN;TONG, ZHAOLONG;LONG, KAI;DOWDELL, SARAH E.;MANAS, ERIC STEVEN;GOODMAN, KRISTA BEAVER |
